TABLE A3.
Association between psychosocial factors at work and severe adverse reaction (e.g., anaphylaxis) of COVID‐19 vaccines: multiple logistic regression analysis in the entire sample (N = 747).
| Model 1 | Model 2 | Model 3 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P | |
| Job demand (score, 3–12) | 0.98 | 0.81–1.18 | .814 | 0.96 | 0.80–1.17 | .702 | 1.01 | 0.83–1.23 | .918 |
| Job control (score, 3–12) | 0.97 | 0.78–1.19 | .748 | 0.97 | 0.79–1.20 | .768 | 0.95 | 0.76–1.18 | .643 |
| Coworker support (score, 3–12) | 0.79 | 0.61–1.02 | .074 | 0.83 | 0.63–1.08 | .170 | 0.82 | 0.62–1.09 | .170 |
| Supervisor support (score, 3–12) | 1.37 | 1.06–1.77 | .015* | 1.37 | 1.05–1.80 | .020* | 1.36 | 1.04–1.79 | .027* |
| Gender (women vs. men) | 1.77 | 0.64–4.89 | .273 | 2.16 | 0.74–6.33 | .161 | |||
| Age (years) | 0.99 | 0.94–1.04 | .619 | 0.99 | 0.94–1.04 | .575 | |||
| Education (university+ vs. less than university) a | 0.61 | 0.22–1.67 | .336 | 0.60 | 0.22–1.66 | .327 | |||
| Marital status (married vs. single) | 1.51 | 0.58–3.95 | .402 | 1.65 | 0.62–4.40 | .315 | |||
| Occupation (ref: managers) | |||||||||
| Non‐manual workers | 1.98 | 0.22–17.91 | .544 | 2.37 | 0.26–21.80 | .445 | |||
| Manual workers | 2.80 | 0.29–27.35 | .377 | 3.50 | 0.35–35.23 | .288 | |||
| Healthcare workers | 3.22 | 0.17–61.12 | .436 | 3.47 | 0.18–67.27 | .411 | |||
| Chronic disease (any vs. none) | 0.71 | 0.15–3.31 | .663 | 0.97 | 0.20–4.67 | .965 | |||
| Vaccination (second vs. first time) | 1.60 | 0.20–12.93 | .657 | 1.53 | 0.19–12.42 | .692 | |||
| Type of vaccine (ref: Pfizer/BioNTech) | |||||||||
| Moderna | 1.25 | 0.47–3.34 | .651 | 1.23 | 0.46–3.31 | .682 | |||
| Unknown | 7.48 | 1.75–31.91 | .007* | 7.08 | 1.60–31.32 | .010* | |||
| Anxiety about adverse reactions of vaccination (score, 1–4) | 0.72 | 0.40–1.29 | .263 | ||||||
| Fear and worry about COVID‐19 (score, 1–6) | 0.89 | 0.61–1.30 | .541 | ||||||
| Psychological distress (K6 score, 0–24) | 0.97 | 0.89–1.06 | .464 | ||||||
Note: Severe adverse reaction was defined as self‐reported severe reactions requiring medical care after vaccination (e.g., anaphylaxis). Severe adverse effects were observed in n = 22 (of the entire sample) and n = 16 (of the participants without hospital admissions/home treatment).
Abbreviations: CI, confidence interval; OR, odds ratio.
a
Educational attainment was dichotomized into two categories. Missing or unknown was classified as less than university attainment.
*
P < .05.